Steven T Miller

This inventor holds 28 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Alcon Research, Ltd., Alcon Universal Ltd., Arrowhead Pharmaceuticals, Inc.. Active years: 1994-2017.

USPTO Granted Patents = 28 (Patent Applications = 4)

% Patents Active = 64.3

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 67(Granted Patents)

Company Filing History:

Arrowhead Pharmaceuticals, Inc.

patents

4. 3 out of 449

Alcon Laboratories, Inc.

Arrowhead Research Corporation

patents

7. 2 out of 834,411

Other

patents

Years Active: 1994-2017

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9765340 - RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders (2017-09-19),

2. 9745585 - RNAi-mediated inhibition of histamine receptor H1-related conditions (2017-08-29),

3. 9453220 - RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders (2016-09-27),

4. 9447419 - RNAi-mediated inhibition of tumor necrosis factor α-related conditions (2016-09-20),

5. 9371529 - RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions (2016-06-21),

6. 9206428 - RNAi-mediated inhibition of histamine receptor H1-related conditions (2015-12-08),

7. 8865671 - RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions (2014-10-21),

8. 8673873 - RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders (2014-03-18),

9. 8618278 - RNAi-mediated inhibition of histamine receptor H1-related conditions (2013-12-31),

10. 8541389 - RNAi-mediated inhibition of tumor necrosis factor α-related conditions (2013-09-24),

11. 8222227 - RNAi-mediated inhibition of histamine receptor H1-related conditions (2012-07-17),

12. 8048863 - RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions (2011-11-01),

13. 8017592 - RNAi-mediated inhibition of histamine receptor H1-related conditions (2011-09-13),

14. 7906512 - 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases (2011-03-15),

15. 7799778 - 5-substituted 2-aminopyridine analogs for treating allergic and inflammatory diseases (2010-09-21),

Title: The Inventor Steven T Miller from Arlington, TX

Introduction: Steven T Miller is a prolific inventor based in Arlington, Texas, known for his groundbreaking contributions to various fields.

Latest Patents: Steven T Miller holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: Throughout his career, Steven T Miller has demonstrated a keen ability to transform creative concepts into tangible inventions that have made a significant impact on industries worldwide.

Collaborations: Steven T Miller has collaborated with leading companies, research institutions, and universities to further develop and commercialize his inventions, solidifying his reputation as a visionary inventor.

Conclusion: Steven T Miller's passion for innovation and his relentless pursuit of excellence continue to drive his success in the world of inventions, making him a respected figure in the field.